Dominari Holdings Enters Inducement Agreements to Modify Series A Warrants

What Happened

• Dominari Holdings Inc. announced on August 13, 2026 that it entered into inducement agreements with certain holders of its Series A warrants (originally issued Feb 14, 2025) to reduce market overhang from outstanding warrants.
• Holders were given two choices: (A) exercise all their existing Series A warrants for cash by 4:00 p.m. ET on September 11, 2026 at a reduced exercise price of $2.20 per share (down from the original $3.72), or (B) exchange all unexercised warrants at a 5:1 ratio (five warrant shares converted into one share of Common Stock) for no additional consideration. The shares issuable on exercise remain registered under the company’s effective S-3 (No. 333-286648).

Key Details

• Aggregate shares underlying the Series A warrants subject to the agreements: up to 3,124,690 shares.
• Expected gross proceeds if Holders choose cash exercise (Option A): approximately $2.9 million.
• Expected shares to be issued under exchanges (Option B): about 115,000 shares, issued under the Section 3(a)(9) exemption.
• After the transactions, the company expects roughly 1.2 million unexercised Series A warrants to remain outstanding.

Why It Matters

• This action is intended to reduce the number of outstanding warrants that can create selling pressure (a “warrant overhang”) and to accelerate potential cash proceeds for the company.
• Investors should note two potential impacts: (1) a successful cash-exercise outcome would bring near-term cash of roughly $2.9M and increase outstanding common shares upon exercise; (2) the exchange option reduces the number of warrants but issues fewer shares per surrendered warrant (5:1), also affecting dilution differently than a straight cash exercise.
• The reduced exercise price ($2.20) may materially increase the likelihood of warrant holders exercising for cash versus waiting or letting warrants expire, which is relevant for expected dilution and company liquidity.